መነሻ › ሲ.ኦ.ፒ.ዲ › Texas › Dallas
በDallas፣ TX ለሲ.ኦ.ፒ.ዲ የሚደረጉ ክሊኒካዊ ጥናቶች
ለሲ.ኦ.ፒ.ዲ የሚደረጉ 12 ጥናቶች በDallas እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
ተሳታዮችን በመፈለግ ላይደረጃ 3
- IntraCare- Site Number : 8400034, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Texas Health Presbyterian Hospital Dallas- Site Number : 8400032, Dallas
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
ተሳታዮችን በመፈለግ ላይ
- University of Texas Southwestern, Dallas
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Research Site, Dallas
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Dallas
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Alina Clinical Trials, LLC., Dallas
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- GC2501 Study Site 109, Dallas
STRIVE Post-Market Registry Study
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern, Dallas
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
ተሳታዮችን በመፈለግ ላይደረጃ 3
- GSK Investigational Site, Dallas
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Liver Center of Texas, Dallas
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- GSK Investigational Site, Dallas
በሌሎች ከተሞች ለሲ.ኦ.ፒ.ዲ የሚደረጉ ጥናቶች
- Philadelphia, PA23 ጥናቶች
- Miami, FL18 ጥናቶች
- Birmingham, AL17 ጥናቶች
- Boston, MA17 ጥናቶች
- Orlando, FL15 ጥናቶች
- Houston, TX15 ጥናቶች
- Baltimore, MD14 ጥናቶች
- Chicago, IL14 ጥናቶች
- Pittsburgh, PA12 ጥናቶች
- New York City, NY11 ጥናቶች
- Ann Arbor, MI10 ጥናቶች
- Los Angeles, CA9 ጥናቶች
በDallas ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር55 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር52 ጥናቶች
- Metastatic Cancer42 ጥናቶች
- የልብ ድካም42 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)37 ጥናቶች
- የፕሮስቴት ካንሰር36 ጥናቶች
- የኮሎሬክታል ካንሰር33 ጥናቶች
- ከባድ ሰውነት30 ጥናቶች
- የእንቁላል ካንሰር28 ጥናቶች
- የሽንት ፊኛ ካንሰር27 ጥናቶች
- የሳንባ ካንሰር27 ጥናቶች
- የኤንዶሜትሪየም ካንሰር24 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።